Aprea Therapeutics
APRE
#10393
Rank
NZ$10.18 M
Marketcap
NZ$1.46
Share price
9.39%
Change (1 day)
-66.87%
Change (1 year)

Earnings for Aprea Therapeutics (APRE)

Earnings in 2025 (TTM): -NZ$23.87 Million

According to Aprea Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$23.85 Million, an increase over its 2023 earnings that were of -NZ$25.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aprea Therapeutics from 2019 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$23.87 Million0.1%
2024 -NZ$23.85 Million-7.45%
2023 -NZ$25.76 Million-58.6%
2022 -NZ$62.23 Million-0.2%
2021 -NZ$62.35 Million-29.09%
2020 -NZ$87.93 Million64.34%
2019 -NZ$53.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Magellan Health
MGLN
NZ$35.67 M-255.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Amedisys
AMED
NZ$0.24 B-1,180.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Healthcare Services Group
HCSG
NZ$94.07 M-508.94%๐Ÿ‡บ๐Ÿ‡ธ USA